Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

BACKGROUND: One quarter to one third of patients eligible for systemic thrombolysis are on antiplatelet therapy at presentation. In this study, we aimed to assess the safety and efficacy of intravenous thrombolysis in stroke patients on prescribed antiplatelet therapy in the WAKE-UP trial. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Frey, Benedikt M., Boutitie, Florent, Cheng, Bastian, Cho, Tae-Hee, Ebinger, Martin, Endres, Matthias, Fiebach, Jochen B., Fiehler, Jens, Ford, Ian, Galinovic, Ivana, Königsberg, Alina, Puig, Josep, Roy, Pascal, Wouters, Anke, Magnus, Tim, Thijs, Vincent, Lemmens, Robin, Muir, Keith W., Nighoghossian, Norbert, Pedraza, Salvador, Simonsen, Claus Z., Gerloff, Christian, Thomalla, Götz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678217/
https://www.ncbi.nlm.nih.gov/pubmed/33324940
http://dx.doi.org/10.1186/s42466-020-00087-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678217/
https://www.ncbi.nlm.nih.gov/pubmed/33324940
http://dx.doi.org/10.1186/s42466-020-00087-9

Ejemplares similares